Global Stroke Management Market Report to 2030 - Opportunity Analysis and Industry Forecasts
DUBLIN, June 8, 2022 /PRNewswire/ -- The "Stroke Management Market by Type and Application: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.
The global stroke management market was valued at $31,702.20 million in 2020, and is projected to reach $67,771.95 million by 2030, registering a CAGR of 7.8% from 2021 to 2030.
Stroke is caused by lack of blood flow to the brain which can be caused either due to the blockage of the blood supply or a blood vessel within the brain. Such blood insufficiency causes the brain tissue to die, owing to lack of oxygen for the functioning of the brain, eventually resulting into stroke. Stroke is a medical emergency that requires urgent diagnosis and treatment to minimize brain damage.
According to the Centers for Disease Control and Prevention, in 2018, stroke was responsible for one out of every six fatalities caused by cardiovascular disease. Stroke is a leading cause of serious long-term disability. Ischemic stroke, hemorrhagic stroke, and transient ischemic stroke are the three main types of strokes. The main symptoms of stroke are difficulty in speaking, understanding, and walking; headache; numbness or inability to move parts of face, arm, or leg; gradual loss of vision; and others.
Increase in healthcare awareness, rise in incidence of diabetes, surge in number of tobacco users, and growth in geriatric population drive the growth of the market. Moreover, technological advancements for the diagnosis and treatment of stroke also contribute toward the growth of the market. However, high cost of diagnosis and treatment and lack of reimbursement policies are the major barriers for the growth of the market. Ongoing R&D activities in the field of stroke management are expected to offer lucrative opportunities for market expansion during the forecast period.
The stroke management market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into diagnostics and therapeutics. The diagnostics segment is classified into computed tomography scan (CT scan), magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others.
The therapeutics segment is classified into tissue plasminogen activator, anticoagulant, antiplatelet, and antihypertensive. By application, it is segmented into ischemic stroke and hemorrhagic stroke. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits
- This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2030, which assists to identify the prevailing market opportunities
- An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans
- A comprehensive analysis of the factors that drive and restrain the growth of the stroke management market is provided
- An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves
- Key market players and their strategies have been analyzed to understand the competitive outlook of the market
Key Topics Covered:
Chapter 1: Introduction
Chapter 2: Executive Summary
Chapter 3: Market Landscape
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power Among Buyers
3.4. Market Share Analysis/Top Player Positioning
3.4.1. Market Share Analysis/Top Player Positioning 2020
3.5. Market Dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. Covid-19 Impact Analysis
3.7. Market Volume and Forecast
Chapter 4: Stroke Management Market, by Type
4.1. Market Overview
4.1.1Market Size and Forecast, by Type
4.2. Diagnostics
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, by Region
4.2.3. Market Share Analysis, by Country
4.2.4. Computed Tomography Scan
4.2.4.1. Market Size and Forecast
4.2.4.2.2. Market Volume and Forecast
4.2.5. Magnetic Resonance Imaging
4.2.5.1. Market Size and Forecast
4.2.5.2.2. Market Volume and Forecast
4.2.6. Carotid Ultrasound
4.2.6.1. Market Size and Forecast
4.2.6.2.2. Market Volume and Forecast
4.2.7. Cerebral Angiography
4.2.7.1. Market Size and Forecast
4.2.7.2.2. Market Volume and Forecast
4.2.8. Electrocardiography
4.2.8.1. Market Size and Forecast
4.2.8.2.2. Market Volume and Forecast
4.2.9. Echocardiography
4.2.9.1. Market Size and Forecast
4.2.9.2.2. Market Volume and Forecast
4.2.10. Others
4.2.10.1. Market Size and Forecast
4.2.10.2.2. Market Volume and Forecast
4.3. Therapeutics
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, by Region
4.3.3. Market Share Analysis, by Country
4.3.4. Tissue Plasminogen Activator
4.3.4.1. Market Size and Forecast
4.3.4.2.2. Market Volume and Forecast
4.3.5. Anticoagulant
4.3.5.1. Market Size and Forecast
4.3.5.2.2. Market Volume and Forecast
4.3.6. Antiplatelet
4.3.6.1. Market Size and Forecast
4.3.6.2.2. Market Volume and Forecast
4.3.7. Antihypertensive
4.3.7.1. Market Size and Forecast
4.3.7.2.2. Market Volume and Forecast
Chapter 5: Stroke Management Market, by Application
5.1. Market Overview
5.1.1Market Size and Forecast, by Application
5.2. Ischemic Stroke
5.2.1. Market Size and Forecast, by Region
5.2.2. Market Share Analysis, by Country
5.3. Haemorrhagic Stroke
5.3.1. Market Size and Forecast, by Region
5.3.2. Market Share Analysis, by Country
Chapter 6: Stroke Management Market, by Region
Chapter 7: Company Profiles
7.1. Abbott Laboratories
7.1.1. Company Overview
7.1.2. Key Executives
7.1.3. Company Snapshot
7.1.4. Operating Business Segments
7.1.5. Product Portfolio
7.1.6. Business Performance
7.1.7. Key Strategic Moves and Developments
7.2. B Braun Melsungen AG
7.2.1. Company Overview
7.2.2. Key Executives
7.2.3. Company Snapshot
7.2.4. Operating Business Segments
7.2.5. Product Portfolio
7.2.6. Business Performance
7.2.7. Key Strategic Moves and Developments
7.3. Boston Scientific Corporation
7.3.1. Company Overview
7.3.2. Key Executives
7.3.3. Company Snapshot
7.3.4. Operating Business Segments
7.3.5. Product Portfolio
7.3.6. Business Performance
7.3.7. Key Strategic Moves and Developments
7.4. Bristol Myers Squibb Co.
7.4.1. Company Overview
7.4.2. Key Executives
7.4.3. Company Snapshot
7.4.4. Operating Business Segments
7.4.5. Product Portfolio
7.4.6. Business Performance
7.4.7. Key Strategic Moves and Developments
7.5. Cardinal Health Inc.
7.5.1. Company Overview
7.5.2. Key Executives
7.5.3. Company Snapshot
7.5.4. Operating Business Segments
7.5.5. Product Portfolio
7.5.6. Business Performance
7.5.7. Key Strategic Moves and Developments
7.6. General Electric Company
7.6.1. Company Overview
7.6.2. Key Executives
7.6.3. Company Snapshot
7.6.4. Operating Business Segments
7.6.5. Product Portfolio
7.6.6. Business Performance
7.6.7. Key Strategic Moves and Developments
7.7. GlaxoSmithKline plc
7.7.1. Company Overview
7.7.2. Key Executives
7.7.3. Company Snapshot
7.7.4. Operating Business Segments
7.7.5. Product Portfolio
7.7.6. Business Performance
7.7.7. Key Strategic Moves and Developments
7.8. Medtronic plc
7.8.1. Company Overview
7.8.2. Key Executives
7.8.3. Company Snapshot
7.8.4. Operating Business Segments
7.8.5. Product Portfolio
7.8.6. Business Performance
7.8.7. Key Strategic Moves and Developments
7.9. Merck and Co. Inc.
7.9.1. Company Overview
7.9.2. Key Executives
7.9.3. Company Snapshot
7.9.4. Operating Business Segments
7.9.5. Product Portfolio
7.9.6. Business Performance
7.9.7. Key Strategic Moves and Developments
7.10. Siemens AG
7.10.1. Company Overview
7.10.2. Key Executives
7.10.3. Company Snapshot
7.10.4. Operating Business Segments
7.10.5. Product Portfolio
7.10.6. Business Performance
7.10.7. Key Strategic Moves and Developments
For more information about this report visit https://www.researchandmarkets.com/r/gcpkwv
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article